Key points are not available for this paper at this time.
The DOTA(GSG)-KCCYSL peptide has the potential to be used as a tumor-imaging agent and a vehicle for specific delivery of radionuclide or cytotoxic agents for tumors overexpressing ErbB-2.
Kumar et al. (Mon,) studied this question.